JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1376
Alphatec Holdings
ATEC
$1.6B
| $28.3M | ﹤0.01% |
1,812,138
-259,563
| -13% | -$3.67M |
2019 Q2
15 quarters
|
|
1377
Viatris
VTRS
$20.2B
| $28.2M | ﹤0.01% |
2,935,315
-2,687,486
| -48% | -$29.8M |
2013 Q2
39 quarters
|
|
1378
First Trust Capital Strength ETF
FTCS
$7.41B
| $28.2M | ﹤0.01% |
386,944
+265,070
| +217% | +$19.5M |
2019 Q2
15 quarters
|
|
1379
Algonquin Power & Utilities
AQN
$3.9B
| $28.2M | ﹤0.01% |
3,359,162
+105,671
| +3% | +$795K |
2017 Q1
24 quarters
|
|
|
RETA
1380
CALL
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $28.2M | ﹤0.01% |
+310,000
| New | +$18.2M |
2023 Q1
0 quarters
|
|
1381
Owens Corning
OC
$9.29B
| $28.2M | ﹤0.01% |
293,979
+24,242
| +9% | +$2.29M |
2013 Q2
39 quarters
|
|
1382
Option Care Health
OPCH
$3.47B
| $28.2M | ﹤0.01% |
886,247
+100,456
| +13% | +$3.01M |
2016 Q3
26 quarters
|
|
1383
BHP
BHP
$219B
| $28.1M | ﹤0.01% |
443,705
+114,573
| +35% | +$7.39M |
2013 Q2
39 quarters
|
|
1384
CALL
Chevron
CVX
$405B
| $28.1M | ﹤0.01% |
172,300
+10,600
| +7% | +$1.78M |
2014 Q3
34 quarters
|
|
1385
CALL
Generac Holdings
GNRC
$12.7B
| $28.1M | ﹤0.01% |
260,000
+189,900
| +271% | +$22M |
2022 Q4
1 quarter
|
|
1386
Willis Towers Watson
WTW
$26.7B
| $28.1M | ﹤0.01% |
120,833
+18,076
| +18% | +$4.37M |
2013 Q2
39 quarters
|
|
1387
Lantheus
LNTH
$6.55B
| $28.1M | ﹤0.01% |
340,028
+26,244
| +8% | +$1.69M |
2016 Q4
25 quarters
|
|
1388
Coca-Cola Femsa
KOF
$22.4B
| $28M | ﹤0.01% |
348,412
+76,169
| +28% | +$5.6M |
2015 Q1
32 quarters
|
|
1389
Direxion Daily S&P 500 Bull 2X ETF
SPUU
$293M
| $28M | ﹤0.01% |
+349,996
| New | +$26.7M |
2023 Q1
0 quarters
|
|
1390
Tenaris
TS
$29.5B
| $28M | ﹤0.01% |
984,264
+336,799
| +52% | +$11.1M |
2015 Q3
30 quarters
|
|
1391
Lear
LEA
$5.99B
| $27.9M | ﹤0.01% |
199,686
+41,784
| +26% | +$5.78M |
2013 Q2
39 quarters
|
|
1392
CarMax
KMX
$7.78B
| $27.9M | ﹤0.01% |
433,287
-940,742
| -68% | -$63M |
2013 Q2
39 quarters
|
|
|
IRBT
1393
DELISTED
iRobot
IRBT
| $27.8M | ﹤0.01% |
636,238
-97,665
| -13% | -$4.32M |
2013 Q2
39 quarters
|
|
1394
PUT
State Street Technology Select Sector SPDR ETF
XLK
$131B
| $27.7M | ﹤0.01% |
367,000
+100,200
| +38% | +$6.9M |
2016 Q2
27 quarters
|
|
1395
PUT
Bristol-Myers Squibb
BMY
$120B
| $27.7M | ﹤0.01% |
399,300
-452,100
| -53% | -$31.9M |
2014 Q2
35 quarters
|
|
1396
State Street SPDR S&P Regional Banking ETF
KRE
$3.67B
| $27.6M | ﹤0.01% |
629,636
-410,295
| -39% | -$23.3M |
2013 Q2
39 quarters
|
|
|
PARA
1397
DELISTED
Paramount Global Class B
PARA
| $27.6M | ﹤0.01% |
1,236,460
+63,094
| +5% | +$1.35M |
2013 Q2
39 quarters
|
|
1398
Churchill Downs
CHDN
$5.46B
| $27.6M | ﹤0.01% |
214,548
+22,092
| +11% | +$2.67M |
2013 Q2
39 quarters
|
|
1399
Herbalife
HLF
$1.3B
| $27.5M | ﹤0.01% |
1,711,027
+12,671
| +0.7% | +$224K |
2013 Q2
39 quarters
|
|
1400
Agios Pharmaceuticals
AGIO
$1.85B
| $27.5M | ﹤0.01% |
1,198,513
+15,688
| +1% | +$417K |
2013 Q3
38 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.